Home » Stocks » SILK

Silk Road Medical, Inc. (SILK)

Stock Price: $47.34 USD -0.93 (-1.93%)
Updated May 13, 2021 4:00 PM EDT - Market closed
Market Cap 1.63B
Revenue (ttm) 78.35M
Net Income (ttm) -48.12M
Shares Out 34.34M
EPS (ttm) -1.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $47.34
Previous Close $48.27
Change ($) -0.93
Change (%) -1.93%
Day's Open 48.48
Day's Range 45.85 - 49.11
Day's Volume 613,397
52-Week Range 35.48 - 75.80

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Silk Road Medical (SILK) delivered earnings and revenue surprises of 22.50% and 3.08%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Shares of Silk Road Medical (NASDAQ:SILK) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 3.13% over the past year to ($0.31), which be...

1 week ago - Benzinga

SUNNYVALE, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results ...

1 week ago - GlobeNewsWire

SUNNYVALE, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will ...

1 week ago - GlobeNewsWire

SUNNYVALE, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report ...

3 weeks ago - GlobeNewsWire

SUNNYVALE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment...

4 weeks ago - GlobeNewsWire

APG, FLR, ROCK, SILK, and CYD have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2021

Other stocks mentioned: APG, CYD, FLR, ROCK
1 month ago - Zacks Investment Research

Silk Road Medical (SILK) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

1 month ago - Zacks Investment Research

Bear of the Day: Silk Road Medical (SILK)

2 months ago - Zacks Investment Research

Silk Road Medical (SILK) delivered earnings and revenue surprises of -63.33% and -0.51%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Silk Road Medical (NASDAQ:SILK) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 70.37% over the past year to ($0.46), which m...

2 months ago - Benzinga

Submitted PMA Supplement for ENROUTE Stent in Standard Surgical Risk Patients

2 months ago - GlobeNewsWire

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

SUNNYVALE, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report f...

2 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - February 15, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such inv...

2 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - February 11, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such inv...

3 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - February 6, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such inve...

3 months ago - Newsfile Corp

NEW YORK, Feb. 5, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such investors are advised t...

3 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - January 25, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such inve...

3 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - January 20, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such inve...

3 months ago - Newsfile Corp

SUNNYVALE, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will...

4 months ago - GlobeNewsWire

LONDON--(BUSINESS WIRE)--Deep Pharma Intelligence names Nanox Imaging (NASDAQ:NNOX), TransMedics, Inc. (NASDAQ: TMDX), Outset Medical, Inc. (NASDAQ:OM), Eargo, Inc. (NASDAQ:EAR), and Silk Road Medical, ...

Other stocks mentioned: EAR, NNOX, OM, TMDX
4 months ago - Business Wire

SUNNYVALE, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment ...

5 months ago - GlobeNewsWire

Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Silk Road Medical (SILK) delivered earnings and revenue surprises of -10.71% and 6.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Shares of Silk Road Medical (NASDAQ:SILK) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 19.23% over the past year to ($0.31), wh...

6 months ago - Benzinga

SUNNYVALE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results...

6 months ago - GlobeNewsWire

SUNNYVALE, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will...

6 months ago - GlobeNewsWire

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

SUNNYVALE, Calif., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report f...

6 months ago - GlobeNewsWire

SUNNYVALE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that medical dev...

7 months ago - GlobeNewsWire

SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it is st...

7 months ago - GlobeNewsWire

SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that positive...

7 months ago - GlobeNewsWire

For this report, we analyzed the portfolios of the 13 small-cap growth investment managers with the best 10-year performance records.

Other stocks mentioned: ALRM, AVLR, ETSY, EYE, FIVN, FRPT, IRTC ...
7 months ago - Seeking Alpha

SUNNYVALE, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company w...

8 months ago - GlobeNewsWire

SUNNYVALE, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that ROADSTER ...

8 months ago - GlobeNewsWire

Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Silk Road Medical (SILK) delivered earnings and revenue surprises of 15.79% and 70.94%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

SUNNYVALE, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resul...

9 months ago - GlobeNewsWire

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

SUNNYVALE, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report...

9 months ago - GlobeNewsWire

While most attention in health care has been going to large pharma companies, the charts suggest opportunities in niche subsectors.

Other stocks mentioned: XHE, XHS
9 months ago - Investopedia

SUNNYVALE, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that Andrew Da...

10 months ago - GlobeNewsWire

New Guidelines Consistent with Silk Road Medical Certification Process

10 months ago - GlobeNewsWire

SUNNYVALE, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today ann...

11 months ago - GlobeNewsWire

SUNNYVALE, Calif., May 08, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today ann...

1 year ago - GlobeNewsWire

Investors responded negatively to the medical device company's pricing of a public stock offering.

1 year ago - The Motley Fool

SUNNYVALE, Calif. , May 05, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today an...

1 year ago - GlobeNewsWire

SUNNYVALE, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced...

1 year ago - GlobeNewsWire

About SILK

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid ... [Read more...]

Industry
Medical Devices
IPO Date
Apr 4, 2019
CEO
Erica Rogers
Employees
281
Stock Exchange
NASDAQ
Ticker Symbol
SILK
Full Company Profile

Financial Performance

In 2020, SILK's revenue was $75.23 million, an increase of 18.74% compared to the previous year's $63.35 million. Losses were -$47.37 million, -9.63% less than in 2019.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for SILK stock is "Buy." The 12-month stock price forecast is 67.50, which is an increase of 42.59% from the latest price.

Price Target
$67.50
(42.59% upside)
Analyst Consensus: Buy